ArticleTranslational andrology and urology2025
Harnessing the power of combination therapy: reflecting on the final survival data from the CLEAR study with lenvatinib plus pembrolizumab.
Brian M Shinder et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.